Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Mottok A" with an ORCID

Anja Mottok
No affiliation detected
2
Publications
4,731
Citations
View profile

Search results

1-25 of 102 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.
Hoppe MM, Jaynes P, Shuangyi F, Peng Y, Sridhar S, Hoang PM, Liu CX, De Mel S, Poon L, Chan EHL, Lee J, Ong CK, Tang T, Lim ST, Nagarajan C, Grigoropoulos NF, Tan SY, Hue SS, Chang ST, [...] Jeyasekharan AD
Cancer Discov, 13(5):1144-1163, 01 May 2023
Cited by: 2 articles | PMID: 37071673 | PMCID: PMC10157367
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.
Lopez C, Schleussner N, Bernhart SH, Kleinheinz K, Sungalee S, Sczakiel HL, Kretzmer H, Toprak UH, Glaser S, Wagener R, Ammerpohl O, Bens S, Giefing M, Sanchez JCG, Apic G, Hubschmann D, Janz M, Kreuz M, Mottok A, [...] Siebert R
Haematologica, 108(2):543-554, 01 Feb 2023
Cited by: 1 article | PMID: 35522148
Add to export list
Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
Broséus J, Hergalant S, Vogt J, Tausch E, Kreuz M, Mottok A, Schneider C, Dartigeas C, Roos-Weil D, Quinquenel A, Moulin C, Ott G, Blanchet O, Tomowiak C, Lazarian G, Rouyer P, Chteinberg E, Bernhart SH, Tournilhac O, [...] Stilgenbauer S
Nat Commun, 14(1):309, 19 Jan 2023
Cited by: 10 articles | PMID: 36658118 | PMCID: PMC9852595
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
Johnston RL, Mottok A, Chan FC, Jiang A, Diepstra A, Visser L, Telenius A, Gascoyne RD, Friedman DL, Schwartz CL, Kelly KM, Scott DW, Horton TM, Steidl C
Blood, 139(6):889-893, 01 Feb 2022
Cited by: 6 articles | PMID: 34662378 | PMCID: PMC8832480
Add to export list Free full text in Europe PMC
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
Gerhard-Hartmann E, Goergen H, Bröckelmann PJ, Mottok A, Steinmüller T, Grund J, Zamò A, Ben-Neriah S, Sasse S, Borchmann S, Fuchs M, Borchmann P, Reinke S, Engert A, Veldman J, Diepstra A, Klapper W, Rosenwald A
Br J Haematol, 196(1):116-126, 14 Sep 2021
Cited by: 9 articles | PMID: 34520052
Add to export list
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, Pack S, Clot G, Nadeu F, Mottok A, Horn H, Song JY, Fu K, Wright G, Gascoyne RD, Chan WC, Scott DW, Feldman AL, Valera A, Enjuanes A, Braziel RM, Smeland EB, [...] Campo E
Haematologica, 106(10):2682-2693, 01 Oct 2021
Cited by: 25 articles | PMID: 33951889
Add to export list
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Thurner L, Hartmann S, Bewarder M, Fadle N, Regitz E, Schormann C, Quiroga N, Kemele M, Klapper W, Rosenwald A, Trümper L, Bohle RM, Nimmesgern A, Körbel C, Lascke MW, Menger MD, Barth S, Kubuschok B, Mottok A, [...] Pfreundschuh M
Haematologica, 106(8):2224-2232, 01 Aug 2021
Cited by: 10 articles | PMID: 32675228
Add to export list
Characterization of DLBCL with a PMBL gene expression signature.
Duns G, Viganò E, Ennishi D, Sarkozy C, Hung SS, Chavez E, Takata K, Rushton C, Jiang A, Ben-Neriah S, Woolcock BW, Slack GW, Hsi ED, Craig JW, Hilton LK, Shah SP, Farinha P, Mottok A, Gascoyne RD, [...] Steidl C
Blood, 138(2):136-148, 01 Jul 2021
Cited by: 15 articles | PMID: 33684939
Add to export list
Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma
Arthur SE, Gao J, Healy S, Rushton CK, Thomas N, Hilton LK, Dreval K, Tang J, Alcaide M, Cojocaru R, Mottok A, Telenius A, Unrau P, Wilson WH, Staudt LM, Scott DW, Hodson DJ, Steidl C, Morin RD
bioRxiv, 23 May 2021
Cited by: 0 articles | PPR: PPR344583
Add to export list Preprint
A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas.
Horn H, Kalmbach S, Wagener R, Staiger AM, Hüttl K, Mottok A, Bens S, Traverse-Glehen A, Fontaine J, Siebert R, Rosenwald A, Ott G
Am J Surg Pathol, 45(3):356-364, 01 Mar 2021
Cited by: 18 articles | PMID: 33136583
Add to export list
A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
Bäuerlein CA, Qureischi M, Mokhtari Z, Tabares P, Brede C, Jordán Garrote AL, Riedel SS, Chopra M, Reu S, Mottok A, Arellano-Viera E, Graf C, Kurzwart M, Schmiedgen K, Einsele H, Wölfl M, Schlegel PG, Beilhack A
Front Immunol, 11:593321, 29 Jan 2021
Cited by: 4 articles | PMID: 33584657 | PMCID: PMC7880247
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity.
Xiao Y, Qureischi M, Dietz L, Vaeth M, Vallabhapurapu SD, Klein-Hessling S, Klein M, Liang C, König A, Serfling E, Mottok A, Bopp T, Rosenwald A, Buttmann M, Berberich I, Beilhack A, Berberich-Siebelt F
J Exp Med, 218(1):e20181853, 01 Jan 2021
Cited by: 11 articles | PMID: 32986812 | PMCID: PMC7953626
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns.
Danhof S, Rasche L, Mottok A, Steinmüller T, Zhou X, Schreder M, Kilian T, Strifler S, Rosenwald A, Hudecek M, Einsele H, Gerhard-Hartmann E
Ann Hematol, 100(6):1537-1546, 11 Feb 2021
Cited by: 6 articles | PMID: 33575947 | PMCID: PMC8116297
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.
Collinge B, Ben-Neriah S, Chong L, Boyle M, Jiang A, Miyata-Takata T, Farinha P, Craig JW, Slack GW, Ennishi D, Mottok A, Meissner B, Chavez EA, Gerrie AS, Villa D, Freeman C, Savage KJ, Sehn LH, Morin RD, [...] Scott DW
Blood, 137(16):2196-2208, 01 Apr 2021
Cited by: 19 articles | PMID: 33120427
Add to export list
Mutational landscape of gray zone lymphoma.
Sarkozy C, Hung SS, Chavez EA, Duns G, Takata K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW, Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A, Salles GA, Casasnovas RO, [...] Steidl C
Blood, 137(13):1765-1776, 01 Apr 2021
Cited by: 44 articles | PMID: 32961552
Add to export list
Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma.
Twa DDW, Lee DG, Tan KL, Slack GW, Ben-Neriah S, Villa D, Connors JM, Sehn LH, Mottok A, Gascoyne RD, Scott DW, Steidl C, Savage KJ
Blood, 137(9):1256-1259, 01 Mar 2021
Cited by: 12 articles | PMID: 32967007
Add to export list
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
Punnoose E, Peale FV, Szafer-Glusman E, Lei G, Bourgon R, Do AD, Kim E, Zhang L, Farinha P, Gascoyne RD, Munoz FJ, Martelli M, Mottok A, Salles GA, Sehn LH, Seymour JF, Trnĕný M, Oestergaard MZ, Mundt KE, Vitolo U
Clin Lymphoma Myeloma Leuk, 21(4):267-278.e10, 10 Nov 2020
Cited by: 6 articles | PMID: 33303421
Add to export list
Patterns of oncogene co-expression at single cell resolution in cancer influence survival
Hoppe MM, Jaynes P, Shuangyi F, Peng Y, Hoang PM, Xin L, De Mel S, Poon L, Chan E, Lee J, Ong CK, Tang T, Lim ST, Nagarajan C, Grigoropoulos NF, Tan S, Hue SS, Chang S, Chuang S, [...] Jeyasekharan AD
medRxiv, 23 Oct 2020
Cited by: 0 articles | PPR: PPR229263
Add to export list Preprint
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS.
Seibold M, Stühmer T, Kremer N, Mottok A, Scholz CJ, Schlosser A, Leich E, Holzgrabe U, Brünnert D, Barrio S, Kortüm MK, Solimando AG, Chatterjee M, Einsele H, Rosenwald A, Bargou RC, Steinbrunn T
Haematologica, 105(9):2316-2326, 01 Sep 2020
Cited by: 9 articles | PMID: 33054056 | PMCID: PMC7556628
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Microenvironment in classical Hodgkin lymphoma].
Mottok A
Pathologe, 41(3):254-260, 01 May 2020
Cited by: 0 articles | PMID: 32239325
Add to export list Review
Gene expression profiling of gray zone lymphoma.
Sarkozy C, Chong L, Takata K, Chavez EA, Miyata-Takata T, Duns G, Telenius A, Boyle M, Slack GW, Laurent C, Farinha P, Molina TJ, Copie-Bergman C, Damotte D, Salles GA, Mottok A, Savage KJ, Scott DW, Traverse-Glehen A, Steidl C
Blood Adv, 4(11):2523-2535, 01 Jun 2020
Cited by: 16 articles | PMID: 32516416 | PMCID: PMC7284085
Add to export list Free full text in Europe PMC
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma.
Dheilly E, Battistello E, Katanayeva N, Sungalee S, Michaux J, Duns G, Wehrle S, Sordet-Dessimoz J, Mina M, Racle J, Farinha P, Coukos G, Gfeller D, Mottok A, Kridel R, Correia BE, Steidl C, Bassani-Sternberg M, Ciriello G, [...] Oricchio E
Cancer Cell, 37(5):674-689.e12, 23 Apr 2020
Cited by: 39 articles | PMID: 32330455
Add to export list
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.
Ennishi D, Healy S, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, Viganò E, Gold M, Molday LL, Molday RS, [...] Steidl C
Nat Med, 26(4):577-588, 24 Feb 2020
Cited by: 35 articles | PMID: 32094924 | PMCID: PMC8480332
Add to export list Free full text in Europe PMC
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Mondello P, Tadros S, Teater M, Fontan L, Chang AY, Jain N, Yang H, Singh S, Ying HY, Chu CS, Ma MCJ, Toska E, Alig S, Durant M, de Stanchina E, Ghosh S, Mottok A, Nastoupil L, Neelapu SS, [...] Green MR
Cancer Discov, 10(3):440-459, 08 Jan 2020
Cited by: 72 articles | PMID: 31915197 | PMCID: PMC7275250
Add to export list Free full text in Europe PMC
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling.
Zhang AW, O'Flanagan C, Chavez EA, Lim JLP, Ceglia N, McPherson A, Wiens M, Walters P, Chan T, Hewitson B, Lai D, Mottok A, Sarkozy C, Chong L, Aoki T, Wang X, Weng AP, McAlpine JN, Aparicio S, [...] Shah SP
Nat Methods, 16(10):1007-1015, 09 Sep 2019
Cited by: 159 articles | PMID: 31501550 | PMCID: PMC7485597
Add to export list Free full text in Europe PMC

1-25 of 102 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Mottok A" with an ORCID

Search results

Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.

Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.

A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.

9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.

Characterization of DLBCL with a PMBL gene expression signature.

Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma

A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas.

A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.

Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity.

Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns.

The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.

Mutational landscape of gray zone lymphoma.

Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma.

BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.

Patterns of oncogene co-expression at single cell resolution in cancer influence survival

RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS.

[Microenvironment in classical Hodgkin lymphoma].

Gene expression profiling of gray zone lymphoma.

Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma.

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.

Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling.

Partnerships & funding

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Mottok A" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Mottok A" with an ORCID